EMA Authorised: Vantavo (previously Alendronate sodium and colecalciferol, MSD) (alendronic acid;colecalciferol) — Organon N.V.

View source ↗

Summary

EMA authorised the medication Vantavo, a fixed combination of alendronic acid and colecalciferol, for postmenopausal osteoporosis, with Organon N.V. as the mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Vantavo (alendronic acid;colecalciferol)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis, Postmenopausal. MAH: Organon N.V.. Decision date: 12/02/2026